The Latest Cardiac and Vascular News
PCRonline/News/Industry Press Releases – 04 April, 2017 MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital Emmen, The Netherlands – Dr Gillian Jessurun from Treant Zorggroep, Scheper Hospital has enrolled the first patient in the investigator initiated MASTER DAPT (MAnagement of patients post bioresorbable polymer STEnt […]
PCRonline/News/Industry Press Releases – 15 May, 2017 DUBLIN, Ohio. Cordis, Cardinal Health‘s interventional vascular business, announced today the commercial launch of three new products that further enhance its interventional cardiology product portfolio in Europe, the Middle East, and Africa (EMEA). The addition of the Cordis RAILWAY Sheathless Access System as well […]
NEWS PROVIDED BY – Occlutech – 05 Apr, 2017, 07:00 ET SCHAFFHAUSEN, Switzerland, April 5, 2017 /PRNewswire/ — Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) Occluder. The device is a […]
NEWS PROVIDED BY Janssen Pharmaceuticals, Inc. | 03 Apr, 2017, 08:00 ET TITUSVILLE, N.J., April 3, 2017 /PRNewswire/ — Janssen Pharmaceuticals, Inc. (Janssen) today announced it has collaborated with Premier Inc. on the first and largest study of its kind to address an unmet medical need for hospitalized patients with atrial fibrillation […]
BOSTON, April 4, 2017 /PRNewswire/ — InfoBionic (www.infobionic.com) today announced that Stuart Long was named Chief Executive Officer, underscoring the Company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management. “InfoBionic is redefining the ‘standard of care’ for patients and physicians alike with […]
Endologix Enters into $170 Million Credit Facility with Deerfield Management IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that it has entered into an agreement with Deerfield Management (“Deerfield”), a leading healthcare investment organization, to provide Endologix with up to $170 […]
SAN DIEGO, April 03, 2017 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce it has received CE Mark approval for its Fantom drug-eluting bioresorbable coronary scaffold, which offers multiple and substantial performance advantages over first-generation scaffolds on the market today. Fantom is REVA’s […]
MALVERN, Pennsylvania, April 3, 2017 /PRNewswire/ — Essential Medical, Inc., a privately held medical device company addressing the rapidly growing large bore vascular closure market, announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access” (http://dx.doi.org/10.1016/j.jcin.2016.12.277). This first, […]
April 03, 2017 06:00 AM Eastern Daylight Time OXFORDSHIRE, U.K. & SHANGHAI–(BUSINESS WIRE)–Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading global manufacturer and marketer of a diversified portfolio of medical devices, today announced the parties have […]
Mar 31, 2017 – IRVINE, Calif.–(BUSINESS WIRE)– Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patients were treated in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study, the Company’s pivotal clinical trial to […]
